Kinoloonid (Estonian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kinoloonid" in Estonian language version.

refsWebsite

Global rank Estonian rank

19nih.gov

4^th place

14^th place

8doi.org

2^nd place

16^th place

4web.archive.org

1^st place

4aafp.org

1,916^th place

4,197^th place

2medscape.com

719^th place

379^th place

1fda.gov

447^th place

759^th place

1uchicago.edu

230^th place

571^st place

1cdc.gov

218^th place

383^rd place

1archive.org

6^th place

41^st place

1ama-assn.org

3,257^th place

3,951^st place

1jbc.org

4,455^th place

3,181^st place

1eurekaselect.com

low place

1oxfordjournals.org

1,389^th place

361^st place

1docguide.com

low place

1books.google.com

3^rd place

23^rd place

1sfgate.com

166^th place

2,296^th place

aafp.org

"New Classification and Update on the Quinolone Antibiotics – May 1, 2000 – American Academy of Family Physicians". Originaali arhiivikoopia seisuga 6. juuni 2011. Vaadatud 18. oktoobril 2013.
"New Classification and Update on the Quinolone Antibiotics Review – May, 2000 – American Family Physician".
"Quinolones: A Comprehensive Review – February 1, 2002 – American Family Physician". Originaali arhiivikoopia seisuga 29. september 2007.
Oliphant CM, Green GM (veebruar 2002). "Quinolones: a comprehensive review". Am Fam Physician. 65 (3): 455–64. PMID 11858629. Originaali arhiivikoopia seisuga 29. september 2007. Vaadatud 18. oktoobril 2013.

ama-assn.org

archinte.ama-assn.org

Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO (märts 2003). "Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use". Arch. Intern. Med. 163 (5): 601–5. DOI:10.1001/archinte.163.5.601. PMID 12622607.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)

archive.org

Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS (märts 2005). "Fluoroquinolone prescribing in the United States: 1995 to 2002". The American Journal of Medicine. 118 (3): 259–68. DOI:10.1016/j.amjmed.2004.09.015. PMID 15745724.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)

books.google.com

Gupta (2009). Clinical Ophthalmology: Contemporary Perspectives, 9/e. Elsevier India. Lk 112–. ISBN 978-81-312-1680-4.

cdc.gov

MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)

docguide.com

The European Medicines Agency (24. juuli 2008). "EMEA Restricts Use of Oral Norfloxacin Drugs in UTIs". Doctor's Guide.

doi.org

Hooper, DC. (2001). "Emerging mechanisms of fluoroquinolone resistance" (PDF). Emerg Infect Dis. 7 (2): 337–41. DOI:10.3201/eid0702.010239. PMC 2631735. PMID 11294736.
"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia". Am. J. Respir. Crit. Care Med. 171 (4): 388–416. Veebruar 2005. DOI:10.1164/rccm.200405-644ST. PMID 15699079.
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Liu, H.; Mulholland, SG. (juuli 2005). "Appropriate antibiotic treatment of genitourinary infections in hospitalized patients". Am J Med. 118 Suppl 7A (7): 14S–20S. DOI:10.1016/j.amjmed.2005.05.009. PMID 15993673.
Nelson, JM.; Chiller, TM.; Powers, JH.; Angulo, FJ. (aprill 2007). "Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story" (PDF). Clin Infect Dis. 44 (7): 977–80. DOI:10.1086/512369. PMID 17342653.^{[alaline kõdulink]}
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS (märts 2005). "Fluoroquinolone prescribing in the United States: 1995 to 2002". The American Journal of Medicine. 118 (3): 259–68. DOI:10.1016/j.amjmed.2004.09.015. PMID 15745724.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO (märts 2003). "Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use". Arch. Intern. Med. 163 (5): 601–5. DOI:10.1001/archinte.163.5.601. PMID 12622607.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)

eurekaselect.com

De Sarro, Angela; De Sarro, Giovambattista. "Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects". Current Medicinal Chemistry. 8: 371–384.

fda.gov

accessdata.fda.gov

sanofi-aventis U.S. LLC (september 2008). "NegGram Caplets (nalidixic acid, USP)" (PDF). USA: FDA.

jbc.org

Elsea, Sarah H.; Osheroff, Neil; Nitiss, John L. "Cytotoxicity of Quinolones toward Eukaryotic Cells" (PDF). The Journal of Biological Chemistry. 267: 13150–13153.

medscape.com

Paul G. Ambrose; Robert C. Owens, Jr (1. märts 2000). "Clinical Usefulness Of Quinolones". Seminars in Respiratory and Critical Care Medicine. Medscape.
Paul G. Ambrose; Robert C. Owens, Jr (1. märts 2000). "New Antibiotics in Pulmonary and Critical Care Medicine: Classification Of Quinolones By Generation". USA: Medscape.

nih.gov

pubmed.ncbi.nlm.nih.gov

Ivanov DV, Budanov SV (2006). "[Ciprofloxacin and antibacterial therapy of respiratory tract infections]". Antibiot. Khimioter. (Russian). 51 (5): 29–37. PMID 17310788.{{cite journal}}: CS1 hooldus: tundmatu keel (link)
Hooper, DC. (2001). "Emerging mechanisms of fluoroquinolone resistance" (PDF). Emerg Infect Dis. 7 (2): 337–41. DOI:10.3201/eid0702.010239. PMC 2631735. PMID 11294736.
"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia". Am. J. Respir. Crit. Care Med. 171 (4): 388–416. Veebruar 2005. DOI:10.1164/rccm.200405-644ST. PMID 15699079.
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Liu, H.; Mulholland, SG. (juuli 2005). "Appropriate antibiotic treatment of genitourinary infections in hospitalized patients". Am J Med. 118 Suppl 7A (7): 14S–20S. DOI:10.1016/j.amjmed.2005.05.009. PMID 15993673.
Nelson, JM.; Chiller, TM.; Powers, JH.; Angulo, FJ. (aprill 2007). "Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story" (PDF). Clin Infect Dis. 44 (7): 977–80. DOI:10.1086/512369. PMID 17342653.^{[alaline kõdulink]}
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Linder JA, Huang ES, Steinman MA, Gonzales R, Stafford RS (märts 2005). "Fluoroquinolone prescribing in the United States: 1995 to 2002". The American Journal of Medicine. 118 (3): 259–68. DOI:10.1016/j.amjmed.2004.09.015. PMID 15745724.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Lautenbach E, Larosa LA, Kasbekar N, Peng HP, Maniglia RJ, Fishman NO (märts 2003). "Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate use". Arch. Intern. Med. 163 (5): 601–5. DOI:10.1001/archinte.163.5.601. PMID 12622607.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Morita Y, Kodama K, Shiota S, Mine T, Kataoka A, Mizushima T, Tsuchiya T (juuli 1998). "NorM, a Putative Multidrug Efflux Protein, of Vibrio parahaemolyticus and Its Homolog in Escherichia coli". Antimicrob. Agents Chemother. 42 (7): 1778–82. PMC 105682. PMID 9661020.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Ball P (2000). "Quinolone generations: natural history or natural selection?". J. Antimicrob. Chemother. 46 Suppl T1 (Supplement 3): 17–24. PMID 10997595.
Oliphant CM, Green GM (veebruar 2002). "Quinolones: a comprehensive review". Am Fam Physician. 65 (3): 455–64. PMID 11858629. Originaali arhiivikoopia seisuga 29. september 2007. Vaadatud 18. oktoobril 2013.

ncbi.nlm.nih.gov

Hooper, DC. (2001). "Emerging mechanisms of fluoroquinolone resistance" (PDF). Emerg Infect Dis. 7 (2): 337–41. DOI:10.3201/eid0702.010239. PMC 2631735. PMID 11294736.
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
MacDougall C, Guglielmo BJ, Maselli J, Gonzales R (märts 2005). "Antimicrobial drug prescribing for pneumonia in ambulatory care". Emerging Infect. Dis. 11 (3): 380–4. DOI:10.3201/eid1103.040819. PMC 3298265. PMID 15757551.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Morita Y, Kodama K, Shiota S, Mine T, Kataoka A, Mizushima T, Tsuchiya T (juuli 1998). "NorM, a Putative Multidrug Efflux Protein, of Vibrio parahaemolyticus and Its Homolog in Escherichia coli". Antimicrob. Agents Chemother. 42 (7): 1778–82. PMC 105682. PMID 9661020.{{cite journal}}: CS1 hooldus: mitu nime: autorite loend (link)
Ruiz, J. "Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection". The Journal of Antimicrobial Chemotherapy. 51: 1109–1117 – cit. via PubMed.
Hangas, A; Aasumets, K; Kekäläinen, NJ; Paloheinä, M; Pohjoismäki, JL; Gehold, JM; Goffart, S. "Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2". Nucleic Acids Research.
Talla, V; Veerareddy, PR. "Oxidative Stress Induced by Fluoroquinolones on Treatment for Complicated Urinary Tract Infections in Indian Patients". Journal of Young Pharmacists. 3: 304–309 – cit. via PubMed.

oxfordjournals.org

jac.oxfordjournals.org

Ball P (2000). "Quinolone generations: natural history or natural selection?". J. Antimicrob. Chemother. 46 Suppl T1 (Supplement 3): 17–24. PMID 10997595.

sfgate.com

Schmid, Randolph E. (1. mai 2006). "Drug Company Taking Tequin Off Market". Associated Press. Originaali arhiivikoopia seisuga 25.11.2007. Vaadatud 1. mail 2006.

uchicago.edu

journals.uchicago.edu

Nelson, JM.; Chiller, TM.; Powers, JH.; Angulo, FJ. (aprill 2007). "Fluoroquinolone-resistant Campylobacter species and the withdrawal of fluoroquinolones from use in poultry: a public health success story" (PDF). Clin Infect Dis. 44 (7): 977–80. DOI:10.1086/512369. PMID 17342653.^{[alaline kõdulink]}

web.archive.org

"New Classification and Update on the Quinolone Antibiotics – May 1, 2000 – American Academy of Family Physicians". Originaali arhiivikoopia seisuga 6. juuni 2011. Vaadatud 18. oktoobril 2013.
"Quinolones: A Comprehensive Review – February 1, 2002 – American Family Physician". Originaali arhiivikoopia seisuga 29. september 2007.
Oliphant CM, Green GM (veebruar 2002). "Quinolones: a comprehensive review". Am Fam Physician. 65 (3): 455–64. PMID 11858629. Originaali arhiivikoopia seisuga 29. september 2007. Vaadatud 18. oktoobril 2013.
Schmid, Randolph E. (1. mai 2006). "Drug Company Taking Tequin Off Market". Associated Press. Originaali arhiivikoopia seisuga 25.11.2007. Vaadatud 1. mail 2006.